Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) Appetite Suppressant
Dragon Pharma Sibutramine 20 mg represents a powerful and historically significant tool in the pharmacological management of weight loss and appetite control. As a centrally-acting serotonin-norepinephrine reuptake inhibitor (SNRI), Sibutramine operates on the brain's hunger and satiety centers with remarkable efficacy. Unlike peripheral fat burners that primarily increase metabolism, Sibutramine's core strength lies in its profound ability to suppress appetite and enhance feelings of fullness, making caloric restriction not just manageable but often effortless. For athletes, bodybuilders, and individuals facing stubborn weight plateaus, it provides the mental edge necessary to adhere to strict diets, especially during intense cutting phases or pre-contest preparations where every calorie counts.
Manufactured to exacting standards in Dragon Pharma's European facilities, each 20 mg tablet delivers a consistent dose of Sibutramine Hydrochloride. The compound works by inhibiting the reuptake of key neurotransmitters—serotonin and norepinephrine—in the synaptic cleft. This elevation in neurochemical activity directly stimulates satiety centers in the hypothalamus (reducing hunger) while simultaneously providing a mild to moderate boost in thermogenesis via the sympathetic nervous system. The dual-action result is a powerful one-two punch: significantly reduced caloric intake coupled with a slight increase in daily energy expenditure. Users consistently report a dramatic reduction in food cravings, particularly for carbohydrates and sweets, and an enhanced ability to maintain disciplined eating patterns for extended periods.
IMPORTANT SAFETY NOTICE: Sibutramine (formerly marketed as Meridia/Reductil) was withdrawn from many prescription markets due to findings of increased cardiovascular risk in patients with pre-existing heart conditions. This product is intended for informed use by healthy individuals with no history of cardiovascular disease, hypertension, stroke, or glaucoma. It is not a benign supplement. Regular monitoring of blood pressure and heart rate is MANDATORY. It must not be combined with other serotonergic agents (e.g., SSRIs, SNRIs, certain opioids) due to the risk of serotonin syndrome. This is a potent compound that demands respect, research, and responsible use.
Key Benefits:
Each sachet contains 100 tablets of 20mg Sibutramine Hydrochloride, manufactured under strict quality control standards in Dragon Pharma's certified facilities.
| Product Name | Sibutramine 20 mg |
| Manufacturer | Dragon Pharma |
| Substance | Sibutramine Hydrochloride |
| Packaging | 100 tablets in sealed sachet |
| Lab Test Result | Pharmaceutical-grade composition assured |
| Half-Life | Approximately 1-3 hours (active metabolites 14-16 hours) |
| Recommended Cycle | 8 - 12 weeks, followed by a break |
| Form | Oral tablet |
| Aromatization | No (Not a steroid) |
| Dosage (Adults) | 10 - 20 mg per day (taken in morning) |
SAFETY FIRST: Do not use if you have hypertension, heart disease, a history of stroke, glaucoma, or are taking other serotonergic drugs (many antidepressants, tramadol, etc.). Obtain a baseline blood pressure reading. The goal is efficacy WITH safety.
Sibutramine does not require a traditional steroid PCT. However, after 8-12 weeks of SNRI activity, a gradual taper is advised rather than abrupt cessation to minimize potential rebound hunger or mild mood changes. Consider reducing to 10 mg daily for the final 7-10 days. Post-cycle, focus on maintaining new eating habits. Natural serotonin support (5-HTP, L-Tryptophan) may be considered after a full washout period (2+ weeks) to support mood, but never concurrently with Sibutramine. For general metabolic health after a cut, a peptide like Tesamorelin could be explored.
This is non-negotiable. You must monitor your resting blood pressure and heart rate at least twice weekly. Discontinue use if systolic BP exceeds 140 mmHg or diastolic exceeds 90 mmHg, or if resting heart rate is consistently above 100 BPM. Support cardiovascular health with Magnesium, Omega-3 fatty acids, and maintaining excellent hydration. Avoid all other stimulants (caffeine, pre-workouts, Clenbuterol) while using Sibutramine. For liver health, a simple support supplement like Milk Thistle is sufficient, as Sibutramine is not hepatotoxic.
To maintain the chemical stability and shelf life of Sibutramine tablets, adhere to the following storage conditions:
Sibutramine is a centrally-acting serotonin-norepinephrine reuptake inhibitor (SNRI). It works by increasing the levels of these two neurotransmitters in the brain, specifically in the hypothalamus. This action has two primary effects: 1) Appetite Suppression: It enhances feelings of fullness (satiety) and reduces hunger signals, making it easier to consume fewer calories. 2) Increased Thermogenesis: It slightly boosts the metabolic rate by stimulating the sympathetic nervous system, leading to increased energy expenditure. The combined result is a significant reduction in caloric intake and a moderate increase in calories burned, creating a powerful deficit for weight loss.
Sibutramine's mechanism is most similar to other centrally-acting appetite suppressants that affect monoamine neurotransmitters. The closest pharmaceutical analogues were drugs like Fenfluramine/Phentermine (Fen-Phen) and Dexfenfluramine, which were also serotoninergic agents (since withdrawn). In terms of current prescription weight-loss medications, Lorcaserin (Belviq) had a similar serotonin-focused action but was more selective. Modern GLP-1 agonists like Semaglutide (Wegovy/Ozempic) and Tirzepatide (Mounjaro) work through completely different pathways (incretin hormones). Among athletes, Sibutramine is often compared to other strong appetite suppressants but is unique in its dual SNRI action.
Sibutramine (brand name Meridia/Reductil) was withdrawn from major markets like the US, EU, and others around 2010 following the SCOUT study. This large-scale trial found a small but statistically significant increase in the risk of major cardiovascular events (non-fatal heart attack, non-fatal stroke, cardiac arrest, or death) in patients with pre-existing cardiovascular disease. The risk-benefit profile was deemed unfavorable for the general overweight population, leading to its suspension. It's crucial to understand that this risk is primarily associated with individuals with underlying heart conditions, hypertension, or a history of stroke. Healthy individuals using it at moderate doses for short periods under informed consent may perceive the risk differently, but caution is paramount.
Common side effects are mostly related to its adrenergic and serotonergic activity and can include:
Less common but serious side effects include heightened risk of serotonin syndrome (especially if combined with other serotonergic drugs), mania in predisposed individuals, and the cardiovascular risks noted above. Monitoring blood pressure and heart rate regularly is essential during use.
Sibutramine should always be started at the lowest effective dose. For Dragon Pharma's 20 mg tablets, this typically means beginning with a HALF tablet (10 mg) taken once daily in the morning. This dose can be maintained for 1-2 weeks to assess tolerance, particularly monitoring blood pressure and heart rate. If well-tolerated and more suppression is needed, the dose can be increased to one full 20 mg tablet daily. The maximum daily dose should not exceed 20 mg. It is usually taken continuously for cycles of 8-12 weeks, followed by a break. It should NOT be combined with other serotonergic drugs (e.g., many antidepressants) or stimulants due to the risk of serotonin syndrome and cardiovascular strain.
Multi-Ester Testosterone Blend (5 Esters)